全文获取类型
收费全文 | 88077篇 |
免费 | 7226篇 |
国内免费 | 5832篇 |
专业分类
耳鼻咽喉 | 2002篇 |
儿科学 | 395篇 |
妇产科学 | 2387篇 |
基础医学 | 4964篇 |
口腔科学 | 539篇 |
临床医学 | 9488篇 |
内科学 | 9274篇 |
皮肤病学 | 350篇 |
神经病学 | 647篇 |
特种医学 | 5072篇 |
外国民族医学 | 52篇 |
外科学 | 17758篇 |
综合类 | 15762篇 |
现状与发展 | 3篇 |
预防医学 | 2507篇 |
眼科学 | 227篇 |
药学 | 4453篇 |
17篇 | |
中国医学 | 776篇 |
肿瘤学 | 24462篇 |
出版年
2024年 | 81篇 |
2023年 | 884篇 |
2022年 | 1816篇 |
2021年 | 2418篇 |
2020年 | 2391篇 |
2019年 | 2049篇 |
2018年 | 1877篇 |
2017年 | 2208篇 |
2016年 | 2920篇 |
2015年 | 2750篇 |
2014年 | 5463篇 |
2013年 | 4709篇 |
2012年 | 5875篇 |
2011年 | 6340篇 |
2010年 | 5522篇 |
2009年 | 5383篇 |
2008年 | 5437篇 |
2007年 | 5956篇 |
2006年 | 5605篇 |
2005年 | 5342篇 |
2004年 | 4072篇 |
2003年 | 3581篇 |
2002年 | 3067篇 |
2001年 | 2965篇 |
2000年 | 2451篇 |
1999年 | 1847篇 |
1998年 | 1531篇 |
1997年 | 1371篇 |
1996年 | 894篇 |
1995年 | 781篇 |
1994年 | 662篇 |
1993年 | 411篇 |
1992年 | 349篇 |
1991年 | 307篇 |
1990年 | 272篇 |
1989年 | 251篇 |
1988年 | 222篇 |
1987年 | 190篇 |
1986年 | 162篇 |
1985年 | 143篇 |
1984年 | 78篇 |
1983年 | 52篇 |
1982年 | 86篇 |
1981年 | 65篇 |
1980年 | 73篇 |
1979年 | 64篇 |
1978年 | 44篇 |
1977年 | 34篇 |
1976年 | 30篇 |
1975年 | 16篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
目的分析江苏省启东市1972—2016年胃癌死亡流行特征。方法收集启东市1972—2016年恶性肿瘤死亡登记数据库及历年人口资料, 计算死亡率、中国人口标化率(中标率)、世界人口标化率(世标率)、35~64岁截缩率、0~74岁累积死亡率、累积死亡风险、变化百分比、死亡率年均变化百分比。结果 1972—2016年启东市胃癌死亡例数为15 863例, 占全部恶性肿瘤死亡例数的16.04%, 胃癌死亡率为31.37/10万, 中标率为12.97/10万, 世标率为21.39/10万, 35~64岁截缩死亡率为28.86/10万, 0~74岁累积死亡率为2.54%, 胃癌死亡累积风险为2.51%。男性死亡10 114例, 男性死亡率、中标率、世标率分别为40.53/10万、17.98/10万和30.13/10万;女性死亡5 749例, 女性死亡率、中标率、世标率分别为22.45/10万、8.52/10万和13.92/10万。25岁以下各年龄组的死亡率<1/10万, 死亡率随年龄的增长而升高, 50~岁组达到并超过人群的平均死亡率水平, 80~岁组达到死亡高峰。1972—2016年间胃癌死... 相似文献
2.
3.
4.
Curcumin Encapsulated into Biocompatible Co-Polymer PLGA Nanoparticle Enhanced Anti-Gastric Cancer and Anti-Helicobacter Pylori Effect 下载免费PDF全文
Jawed AlamFahima DilnawazSanjeeb Kumar SahooDurg Vijai Singh Asish Kumar MukhopadhyayTahziba HussainSanghamitra Pati 《Asian Pacific journal of cancer prevention》2022,23(1):61-70
Background: The current disadvantages (high cost, toxicity, resistance) of chemotherapy for gastric cancer opted people for alternative therapy from natural source. Curcumin (natural product) possess multiple biological activities but low bio-availability limits their uses as therapeutic. The Nano-formulation of curcumin increased the bioavailability and productivity of anti-cancer and anti-bacterial properties. The present study was initiated to determine the anti-cancer and anti-bacterial effect of Nano curcumin against gastric cancer and H. pylori. Methods: Curcumin loaded PLGA nanoparticles (CUR-NPs) was prepared by single emulsion solvent evaporation method. The MIC were determined using agar dilution method to find the anti-H. Pylori activity of Nano curcumin. The cytotoxicity of Nano curcumin was evaluated by MTT assay and the apoptotic effect (cell cycle arrest and morphology change) was shown by PI staining and microscopy. Results: The MIC of nanocurcumin and curcumin for all four H. pylori strains were 8 µg/ml and 16 µg/ml respectively. The inhibition rate of gastric cancer cells after treatment with curcumin was increased from 6% to 67% for 24h, from 8% to 75% for 48h, from 10% to 83% for 72h. In case of nanocurcumin, the inhibition rate increased from 7% to 69% for 24h, 11% to 87% for 48h and 16% to 97% for 72h. The IC50 of curcumin and Nano-curcumin were 24.20 µM and 18.78 µM respectively for 72 h. The population of cells in sub-G0 population increased from 4.1% in the control group to 24.5% and 57.8% when treated with curcumin and nanocurcumin respectively. After 72h of treatment with nanocurcumin, the apoptotic cells population increased as compared to native curcumin treated cells. Conclusion: The Nano curcumin might be used as a potential therapeutics against gastric cancer and H. Pylori. There is need of further in vivo study in order to validate CUR-NPs activity. 相似文献
5.
6.
Tomoe Koizumi PhD Yodo Sugishita MD PhD Yuki Suzuki-Takahashi MD PhD Kazuko Nara MA Tomoko Miyagawa MA Misako Nakajima MA Kouhei Sugimoto MD PhD Manabu Futamura MD PhD Tatsuro Furui MD PhD Yasushi Takai MD PhD Hiroshi Matsumoto MD PhD Hideko Yamauchi MD Shinji Ohno MD PhD Akemi Kataoka MD PhD Kiyotaka Kawai MD PhD Eisuke Fukuma MD PhD Hiroko Nogi MD PhD Koichiro Tsugawa MD PhD Nao Suzuki MD PhD 《Cancer》2023,129(16):2568-2580
7.
探究p53 基因突变与骨髓增殖性肿瘤(MPN)临床特征及预后的关系。方法 选取2017年1月~2020年1月本院收治的MPN患者126例,二代测序法检测患者p53 基因突变情况。对患者进行随访,统计患者总生存(OS)时间和累计生存率;分析p53 基因突变对患者临床特征、预后的影响。结果 126例MPN患者中12例(9.52%)检出p53基因突变,突变主要位于4~8号外显子上,不同类型患者的p53 基因突变检出率比较差异无统计学意义(P>0.05)。p53突变组患者年龄大于p53 非突变组,WBC水平低于p53 非突变组(P<0.05),两组患者的染色体核型、IPSS预后分层比较差异无统计学意义(P>0.05);p53 非突变组患者的OS时间、累计生存率均明显高于p53突变组患者(P<0.05)。结论 MPN患者p53 基因突变发生率较高,与患者年龄、WBC水平、异常核型及IPSS预后分层相关,p53 基因突变会影响患者的预后,可作为临床筛查预后不良高风险人群的客观指标。 相似文献
8.
Lin Li Wei Wu Wanchao Zheng Qiao Hui Chunna Zhao 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2022,130(1):21-25
We aimed to explore the correlation between P27 expression and Helicobacter pylori (H. pylori) infection in gastric cancer, so as to provide evidence for understanding the pathogenesis of gastric cancer caused by H. pylori infection. A total of 82 samples of gastric cancer tissues and 56 samples of tumor-adjacent normal tissues collected from the gastrectomy were enrolled in this study. Then, 14C-urease breathing test was carried out to evaluate the infection of H. pylori in gastric cancer tissues, the expression of P27 in the tissue samples was detected by the immunohistochemistry staining, and the correlation between the H. pylori infection and P27 expression in gastric cancer was analyzed. Of 82 gastric cancer patients, there were 53 patients with H. pylori infection (64.63%). Among the patients with highly or moderately differentiated gastric cancer, the expression of P27 was much higher than that of patients with poorly differentiated gastric cancer (p < 0.01). Besides, comparison of the P27 expression between males and females, among different age groups, tumor sizes, TNM stages, tumor infiltration degrees, or lymph node metastasis, showed no significant differences (p > 0.05). Analysis of the correlation revealed that P27 expression was negatively correlated with the infection of H. pylori (p < 0.01). Multifactorial logistics regression analysis indicated that tumor differentiation was a risk factor of P27-positive expression in gastric cancer tissues (p < 0.01). In addition, P27 expression in the gastric cancer tissues was lower than that in the tumor-adjacent normal tissues (p < 0.01). In gastric cancer patients, expression of P27 is correlated with H. pylori infection which, via downregulating P27, can cause the cancerization of gastric mucosa, and P27, for its role in the development and progression of gastric cancer, is a potential auxiliary indicator for clinical diagnosis whether gastric cancer is complicated with H. pylori infection. So, P27 is a key indicator for diagnosis, treatment, and prognostic evaluation of disease in the advanced stage. 相似文献
9.
子宫浆液性癌(uterine serous carcinoma,USC)是一种特殊类型的子宫内膜癌。有别于常见的子宫内膜样腺癌,USC较为少见,且恶性程度高,侵袭转移风险高,临床上预后较差。随着子宫内膜癌分子学研究的不断深入,分子学特征被应用于子宫内膜癌的病理分型诊断、治疗和预后评价中。研究发现USC中存在多种基因的突变,这些相关基因的突变对该病的诊断和预后具有重要的指导意义。同时,特异性的分子学改变为USC的靶向治疗提供了潜在的治疗靶点。目前,多种靶向治疗手段包括人表皮生长因子受体2(human epidermal growth factor receptor 2,HER2)抑制剂、免疫检查点抑制剂、抗血管生成治疗、磷脂酰肌醇3激酶(phosphoinositide 3-kinases,PI3K)通路抑制剂和多腺苷二磷酸核糖聚合酶[poly(ADP-ribose) polymerase,PARP]抑制剂等被应用于USC的临床治疗研究中,针对性的靶向治疗有望成为USC治疗的新突破。 相似文献
10.